SAS Output

20-AUG-2018 6:10

GU ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1500-pRCC,Adv, Sunitinib vs MET inhib 1 Y 1 Sunitinib 180 25 13 7 5 1 0 07/25/2016 226 95
        2 Cabozantinib   25 16 8 5 2 0      
        3 Crizotinib   28 17 10 7 4 0      
        4 Savolitinib   26 14 8 4 1 1      
            104 60 33 21 8 1      
 
  S1602-Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 Y 1 TICE BCG 969 45 37 21 9 5 0 02/24/2017 151 63
        2 Tokyo-172 BCG   45 38 23 12 4 0      
        3 Prime + Tokyo-172 BCG   45 38 22 11 4 1      
            135 113 66 32 13 1      
 
  S1605-Blad, BCG-Unresponsive NMIBC, Atezolizumab 1 Y 1 Atezolizumab 148 66 59 31 18 9 3 03/13/2017 167 72
            66 59 31 18 9 3      
 
Yes A031102-GCT, Recur, Std Chemo(TIP) vs HD Chemo(TI-CE) 1 E Total Registrations   3 1 1 0 0 0 11/23/2016 67 35
            3 1 1 0 0 0      
 
  EA8143-RCC, HR, Surg +/- Nivolumab (PROSPER) 0 E Total Registrations   19 19 12 4 1 0 09/29/2017 306 141
            19 19 12 4 1 0      
 
    1 E Total Registrations   15 15 9 4 1 0 09/29/2017    
            15 15 9 4 1 0      
 
  NRGGU002-Pros, RT + ADT After RP +/- Adj Docetaxel 1 E Total Registrations   1 1 0 0 0 0 08/24/2017 290 128
            1 1 0 0 0 0      
 
    2 E Total Registrations   1 1 0 0 0 0 08/24/2017    
            1 1 0 0 0 0      
 
No A031501-Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 E Total Registrations   8 8 8 7 0 0 05/03/2018 201 104
            8 8 8 7 0 0      
 
    1 E Total Registrations   7 7 7 7 1 0 05/03/2018    
            7 7 7 7 1 0      
 
  R0924-Pros, NADT+WPRT vs. NADT+P&SV RT 1 E Total Registrations   87 36 21 11 2 0 11/25/2013 368 175
            87 36 21 11 2 0